Please wait
MECURE (MECURE) is listed on the Nigerian Exchange in the HEALTHCARE sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
HEALTHCARE
₦380B
N/A
N/A
Current price
₦94.90
Updated Updated 5h ago
Conviction
41/100
Confidence
Low
Market tone
neutral · 50/100
Entry
Medium · 41/100
Recent price action for MECURE, so the page starts with the stock itself before the deeper analysis.
We do not have enough live liquidity data to judge exits properly yet.
Valuation view
Valuation signal is limited
Income view
Income signal not strong yet
Market tone
neutral (50/100) — price action, attention, and recent context all lean here.
Entry view
Medium (41/100) — The company is profitable on the latest reported numbers.
MECURE operates in the pharmaceutical preparations industry, making and supplying medicines and health-related products. It earns money by selling those products to hospitals, pharmacies, clinics and consumers, and through contracts or distribution agreements.
Investors usually follow MECURE for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Insider sell: Mr. Arjun Udani
Position: Co-CEO b. Sold 200,000,000 shares, on 4 Nov 2024, at ₦6.95 per share, worth ₦1,390,000,000.00. From an official NGX DirectorsDealings filing. Supporting filing text captured.
Director dealings
4
Reported buys, sells, and mixed dealings.
Corporate actions
3
Dividend and company notices.
Market events
0
Insider, filing, dividend, and price events.
Source records
14
Captured updates we can trace.
Whisone is bearish because the bullish case is not yet strong enough to lead while fundamentals are weak at 41/100. Whisone has low conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
34.2%
Return on equity
Debt / equity
2.51
Lower is usually safer.
74/100
Direction
Cautious
Main supports
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Liquidity looks thin, so even a good thesis may take longer to show up in price.
Forecast refresh
Updated 12h ago
Quality score
49
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
Updated 5h ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 20h ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 1d ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 2d ago
Bulk intraday company price snapshot from NGXPulse.
Price points saved
0
P/E: 21.95
Yield: 1.5%
MAYBAKER
MAYBAKER
Price: ₦40.00
P/E: 15.11
Yield: 1.0%
Industry
Pharmaceutical Preparations
Ticker
MECURE
2026-04-24
